abstract |
THE COMPOUNDS AND THEIR PHARMACEUTICAL COMPOSITIONS ARE DIRECTED TO USEFUL METHODS IN THE TREATMENT OF INSOMNIA AND RELATED SLEEP DISORDERS, THE PLATELETARY AGGREGATION, THE CORONARY PATHY, THE MIOCARDIAC INFARCTION, THE ACIDIC ACID CELLULAR, THE ACCIDIC ACIMULAR CELLULAR REDUCE THE RISK OF FORMATION OF BLOOD CLOTS, ASTHMA OR ITS SYMPTOMS, AGITATION OR ITS SYMPTOMS, DRIVING DISORDERS, PSYCHOSIS INDICATED BY DRUGS, ORGANIC PSYCHOSIS WITHOUT SPECIFYING THROUGH US ), PSYCHOTIC DISORDERS, PSYCHOSIS, ACUTE SCHIZOPHRENIA, CHRONIC SKYCHOPHRENIA, NON-SPECIFIED SKISOPHRENIA AND RELATED DISORDERS, DISORDERS RELATED TO DIABETES, MULTIFOCALOPATHARY PROGRESSIVE LEUO-PHYLOPATHARY LEVEL. THIS INVENTION IS ALSO RELATED TO THE METHODS FOR THE TREATMENT OF DISORDERS MEDIATED BY SEROTONINE 5-HT2A RECEIVER IN COMBINATION WITH OTHER DRUGS ADMINISTERED TOGETHER OR SEPARATELY. |